(Q43971097)

28 November 2017

title

Induction of angiogenesis by controlled delivery of vascular endothelial growth factor using nanoparticles (English)

1 reference

28 November 2017

0 references

1 reference

Jiaqi Xie

1

1 reference

28 November 2017

Haibin Wang

2

1 reference

28 November 2017

Yunya Wang

3

1 reference

28 November 2017

Fangping Ren

4

1 reference

28 November 2017

Wei Yi

5

1 reference

28 November 2017

Kun Zhao

6

1 reference

28 November 2017

Zilin Li

7

1 reference

28 November 2017

Qiang Zhao

8

1 reference

28 November 2017

Zhenhua Liu

9

1 reference

28 November 2017

Hong Wu

10

1 reference

28 November 2017

Chunhu Gu

11

1 reference

28 November 2017

Dinghua Yi

12

1 reference

28 November 2017

publication date

1 June 2013

1 reference

Cardiovascular Therapeutics

28 November 2017

published in

1 reference

28 November 2017

volume

31

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

e12-8

1 reference

Angiogenesis: where do we stand now?

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Gene transfer as a tool to induce therapeutic vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Multi-functional nanocarriers for targeted delivery of drugs and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Optimisation of Dex-GMA nanoparticles prepared in modified micro-emulsion system: physical and biologic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

CD13/APN is activated by angiogenic signals and is essential for capillary tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

A model of persistent partial hindlimb ischemia in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Current status of cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Angiogenesis assays: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

A persistent hindlimb ischemia model in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2012.00317.X

10.1111/J.1755-5922.2012.00317.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference